Correlation Between Virax Biolabs and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Tempest Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Tempest Therapeutics.
Diversification Opportunities for Virax Biolabs and Tempest Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Virax and Tempest is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Tempest Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Tempest Therapeutics. In addition to that, Virax Biolabs is 1.41 times more volatile than Tempest Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.12 per unit of volatility. If you would invest 108.00 in Tempest Therapeutics on August 24, 2024 and sell it today you would lose (15.83) from holding Tempest Therapeutics or give up 14.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Tempest Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Tempest Therapeutics |
Virax Biolabs and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Tempest Therapeutics
The main advantage of trading using opposite Virax Biolabs and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |